Jurgen Sota, Silvana Guerriero, Giuseppe Lopalco, Abdurrahman Tufan, Gaafar Ragab, Ibrahim AlMaglouth, Marcello Govoni, Petros P Sfikakis, Micol Frassi, Antonio Vitale, Riza Can Kardas, Paola Triaggianese, Maria Sole Chimenti, Aos A Aboabat, Matteo Piga, Sara Monti, Gian Domenico Sebastiani, Derya Yildirim, Alessandro Conforti, Stefano Gentileschi, Rosanna Dammacco, Andrea Hinojosa-Azaola, Perla Ayumi Kawakami-Campos, Francesca Ruffilli, Jiram Torres-Ruiz, Maissa Thabet, Amira Atig, Piero Ruscitti, Giulia Cataldi, Ombretta Viapiana, Gülen Hatemi, Alican Karakoç, Stefania Costi, Annamaria Iagnocco, Francesca Crisafulli, George Fragoulis, Emanuela Del Giudice, Mohamed Tharwat Hegazy, Maria Pia Paroli, Ali Şahin, Maria Morrone, Florenzo Iannone, Daniela Opris-Belinski, Kazi Nur Asfina, Patrizia Barone, Carla Gaggiano, Hamit Kucuk, Maria Francesca Gicchino, Francesco Carubbi, Valeria Caggiano, Katerina Laskari, Samar Tharwat, Haner Direskeneli, Fatma Alibaz-Oner, Gizem Sevik, Armin Maier, Ahmed Hatem Laymouna, Giacomo Emmi, Nurullah Akkoç, Maria Tarsia, Jessica Sbalchiero, Giovanni Conti, Rosaria Spinella, Francesco La Torre, Enrico Tombetti, Rana Hussein Amin, Angela Mauro, Anastasios Karamanakos, Ester Carreño, Alex Fonollosa, Marco Cattalini, Luciana Breda, Alejandra de-la-Torre, Ewa Wiesik-Szewczyk, Carlos Cifuentes-González, Seza Ozen, Maria Antonietta Mazzei, Gian Marco Tosi, Bruno Frediani, Alberto Balistreri, Ezgi Deniz Batu, Vishali Gupta, Luca Cantarini, Claudia Fabiani
PURPOSE: The clinical relevance of human leukocyte antigen (HLA) subtypes such as HLA-B51 on Behçet's disease (BD)-related uveitis and non-infectious uveitis (NIU) unrelated to BD remains largely unknown. METHODS: Data were prospectively collected from the International AIDA Network Registry for BD and for NIU. We assessed differences between groups (NIU unrelated to BD and positive for HLA-B51, BD-related uveitis positive for HLA-B51 and BD-related uveitis negative for HLA-B51) in terms of long-term ocular complications, visual acuity (VA) measured by best corrected visual acuity (BCVA), anatomical pattern, occurrence of retinal vasculitis (RV) and macular edema over time...
May 17, 2024: Ocular Immunology and Inflammation